Navigation Links
Letrozole Beats Tamoxifen in Breast Cancer Therapy

Novartis' Femara (letrozole), one of a new class of breast cancer drugs, worked better than standard therapy with tamoxifen in treating breast cancer in women// with advanced disease. Femara is a member of a new class of drugs called aromatase inhibitors, which work differently to prevent certain kinds of breast cancer than does tamoxifen.

This new drug, Letrozole shrank tumors better and helped more women survive. The US Food and Drug Administration (FDA) approved Femara as first-line hormonal treatment for advanced breast cancer in postmenopausal women. At that time, an FDA advisory panel enthusiastically backed Femara based on Novartis' research comparing the drug with a generic version of tamoxifen, the gold standard treatment for advanced breast cancer.

Femara was initially approved by the FDA in 1997 as treatment for advanced, hormonally sensitive breast cancer that had not responded to other treatments. Novartis believes Femara may also have potential early in the course of breast cancer and is studying the drug as a pre-surgical therapy.
'"/>




Page: 1

Related medicine news :

1. New Study Confers All Clear Status On Letrozole, Infertility Drug
2. Nasal Spray Beats Antihistamine
3. Identifying Irregular Heart Beats
4. Stomach Beats Can Tell the Truth About Lying
5. Radiation Overdose at the Beatson Oncology Centre
6. Radio Therapy To Cure Irregular Heart Beats
7. For Super-Obese Patients, Duodenal Switch Beats Gastric Bypass
8. Dawn Machine Beats Wintertime Blues
9. Hypertension Treatment: US Beats Europe
10. Low-dose Aspirin Beats High-dose After Cardiac Surgery
11. Tamoxifen does not adversely affect the brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: